產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時(shí)服務(wù)熱線
SK-LU-1 (人低分化肺腺癌細(xì)胞) (STR鑒定正確)
貨號(hào)：CL-0716
規(guī)格：1×10?cells/T25培養(yǎng)瓶
價(jià)格： ￥1800
生長(zhǎng)培養(yǎng)基：MEM（ATCC改良）＋10% FBS＋1% P/S
產(chǎn)品概述
產(chǎn)品信息
| 名稱 | SK-LU-1 (人低分化肺腺癌細(xì)胞) (STR鑒定正確) |
| 別稱 | SK-Lu-1; SK LU 1; SK-Lu1; SK-LU1; SKLU-1; SKLU1 |
| 種屬 | 人 |
| 生長(zhǎng)特性 | 貼壁細(xì)胞 |
| 細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
生長(zhǎng)培養(yǎng)基:
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:2 |
| 推薦換液頻率 | 2-3次/周 |
參考資料(來(lái)源文獻(xiàn))
| 背景描述 | The stemline chromosome number is hypotetraploid, with the 2S component occurring at 4.4%. Marker chromosomes 1p, t(1q;11q); 11q+; t(13;?); 16q+; t(12q; 18q); M10; t(2q;13q); i(15); and ?t(xp;21q) occurred in all S metaphases, and t(1p;?); t(1p;14q); t(16;?), and t(14;21) occurred in some. In addition, 4 to 9 small markers of unidentifiable origin occurred frequently. Chromosome No. 7 was generally hexasomic, X chromosomes were disomic, and normal No. 15 was absent. No Y chromosome was detected in the QM stained preparation. |
| 年齡（性別） | 女性；60歲 |
| 組織來(lái)源 | 肺 |
| 細(xì)胞類型 | 腫瘤細(xì)胞 |
| 腫瘤類型 | 肺腺癌細(xì)胞 |
| 生物安全等級(jí) | BSL-1 |
| 致瘤性 | Yes; Yes, in immunotolerant rats |
| 抗原表達(dá)情況 | Blood Type O; Rh+; HLA Aw24, Aw32, B27, Bw41 |
| 保藏機(jī)構(gòu) | AddexBio; C0016049/5014 ATCC; HTB-57 CLS; 300335 ECACC; 93120835 ICLC; HTL96023 IZSLER; BS TCL 81 KCLB; 30057 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 10 D2S1338 16,17 D3S1358 18 D5S818 11 D7S820 9 D8S1179 10 D13S317 10 D16S539 8 D18S51 18 D19S433 15 D21S11 29,30 FGA 21,22 PentaD 10,13 PentaE 5 TH01 7 TPOX 8,10 vWA 16,17 D6S1043 11 D12S391 23,24 D2S441 11 -
STR鑒定圖
-
參考文獻(xiàn)
文獻(xiàn)列表
-
Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma(2023/06/23)
作者：Mengxi Wu, Zhenyu Wu, Jun Yan
期刊：Frontiers in Oncology
影響因子 ：4.700
-
Development and validation of an endoplasmic reticulum stress long non-coding RNA signature for the prognosis and immune landscape prediction of patients with lung adenocarcinoma(2023/02/20)
作者：Jie Zeng, Zhenyu Wu, Meijuan Luo
期刊：Frontiers in Genetics
DOI：10.3389/fgene.2023.1024444
影響因子 ：3.700
FAQs
Q：{{item.question}}
A：
暫無(wú)數(shù)據(jù)
產(chǎn)品資料
注：百度瀏覽器無(wú)法支持掃一掃功能，請(qǐng)輸入識(shí)別碼，獲取相應(yīng)產(chǎn)品資料
識(shí)別碼示意圖
![U266 [U266B1] (人多發(fā)性骨髓瘤細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0510-1-1.jpg)
娜胡文君.png "邱國(guó)娜/胡文君")
.png "梅文強(qiáng)")
